ArticleFrontiers in dementia2026
The growing potential for multidisciplinary support and technology to enhance person-centred dementia care: a UK and US perspective.
Article in Frontiers in dementia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally more than 55 million people live with dementia, which is estimated to increase threefold by 2050. Dementia poses major challenges for healthcare systems, societies and families, making it a recognised public health priority by the World Health Organization. Advances in pharmacological treatment approaches and new technologies suggest promising improvements in quality-of-life outcomes for people with dementia. However, these new developments may exacerbate existing inequalities in access to dementia treatments and services, depending on how well the organisation and delivery of healthcare services can evolve to successfully link those affected by dementia with treatment options and effective support. In this commentary, we present two important directions to addressing these growing holistic-care challenges and improving life-long quality of life for the patient: firstly, the role of dedicated multidisciplinary support to connect people with dementia to the various services engaged in their care, and secondly the use of technology as an enabler of multidisciplinary care through communication, shared information and coordination within such networks. In particular, we present examples of how artificial intelligence (AI) could be introduced as part of person-centred care during both the diagnosis and monitoring of the disease progression and treatment, to enhance tailoring of personalised therapeutic plans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.